The SNIFF trial of nasal insulin for AD will NOT show a statistically significant improvement in CSF Abeta or CSF Abeta/tau ratio over time (i.e., these will NOT be reported as significant by the study investigators).

Created by Porejide on 2015-11-26; known on 2016-12-31

Please log in to respond to or judge prediction